TAT Cell Penetrating Peptides

Posted by & filed under Blog, Discovery Peptides, Peptide Research, Peptides.

  What’s new? Recent additions to DISCOVERY® Peptides DISCOVERY® Peptides is the new catalogue range from Cambridge Research Biochemicals, the second oldest peptide manufacturer in the world. <![if !mso]>TAT protein (28-35)<![endif]> <![if !mso]>TAT protein (48-59) amide<![endif]> <![if !mso]>TAT-GluR23Y<![endif]> <![if !mso]>gp91 ds-TAT<![endif]> <![if !mso]>TAT-Beclin 1<![endif]> <![if !mso]>TAT-Beclin Scrambled<![endif]> Cambridge Research Biochemicals is a custom peptide provider, therefore if your desired peptide is… Read more »

p21 and phospho-FoxO1: Latest additions to DISCOVERY Antibodies

Posted by & filed under Antibodies, Blog, Discovery Antibodies.

  What’s new? Recent additions to DISCOVERY® Antibodies Discovery® Antibodies is the new catalogue range of antibodies from the revered UK manufacturer Cambridge Research Biochemicals. We have a well-established custom antibody generation operation and we are the second oldest custom peptide manufacturer in the world. Unlike many catalogue antibody and peptide suppliers, our antibodies and antigen peptides are designed… Read more »

Novel Mutation Specific Histone Antibodies generated by Cambridge Research Biochemicals

Posted by & filed under Newsletters.

Novel Mutation Specific Histone Antibodies generated by Cambridge Research Biochemicals In a collaboration with Professor Richard Grundy and Dr Farhana Haque at the Children’s Brain Tumour Research Centre (CBTRC), Layfield and co-workers employed novel mutation specific custom polyclonal antibodies generated by Cambridge Research Biochemicals to discriminate missense (G34R and G34V) mutant histone H3 (H3.3) proteins… Read more »

PNA-Peptide Conjugates Distributed by Cambridge Research Biochemicals

Posted by & filed under Newsletters.

PNA-Peptide Conjugates Distributed by Cambridge Research Biochemicals Complications which arise during pregnancy are often found to be caused by a placental abnormality or malfunction, or poor placental growth and development. Dr Lynda Harris and Colleagues at the University of Manchester have studied the delivery of novel placental homing peptide-miRNA inhibitor PNA conjugates using a mouse… Read more »

September Newsletter 2017

Posted by & filed under Newsletters.

CRB to licence novel fluorescent dyes with the University of Edinburgh  CRB launch highly functional new website for improved user experience Read about the launch of DISCOVERY Antibodies!   CRB to licence novel fluorescent dyes with the University of Edinburgh Cambridge Research Biochemicals® today signed a licence agreement with Edinburgh Innovations, the commercialisation arm of The University… Read more »